Format

Send to

Choose Destination
Crit Rev Eukaryot Gene Expr. 2011;21(2):115-29.

Signaling pathways in pancreatic cancer.

Author information

1
Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03755, USA.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy characterized by a plethora of molecular alterations that include major and minor driving mutations, the presence of intense desmoplasia exhibiting numerous proliferating pancreatic stellate cells (PSC) and cancer-associated fibroblasts that produce fibronectin and collagens, and foci of inflammatory cells that produce mitogenic cytokines. This review will focus on signaling by tyrosine kinase receptors, and the role of transforming growth factor beta in this malignancy is described briefly. Potential for therapeutic interventions will be discussed in relation to specific pathways.

PMID:
22077151
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for BegellHouse Publisher, Inc.
Loading ...
Support Center